section name header

Pronunciation ⬇

kro-FEL-e-mer

Classifications ⬆ ⬇

Therapeutic Classification: antidiarrheals

Pharmacologic Classification: catechins

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • A natural product derived from Croton lechleri, a species of flowering plant.
  • Inhibits cyclic adenosine monophosphate-stimulated cystic fibrosis transmembrane conductance regulator chloride ion channels and the calcium-activated chloride channels on luminal membranes of enterocytes. Blocks chloride secretion and water loss by inhibiting chloride channels on the membranes of enterocytes.
Therapeutic effects:
  • Decreased incidence and severity of diarrhea.

Pharmacokinetics ⬆ ⬇

Absorption: Minimal absorption following oral administration.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
POunknownunknownunknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

EENT: nasopharyngitis

GI: ↑liver function tests, abdominal distention, flatulence, hemorrhoids, nausea

GU: urinary tract infection

MS: arthralgia, back pain, musculoskeletal pain

Neuro: anxiety

Resp: bronchitis, cough, upper respiratory tract infection

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Mytesi